1. Home
  2. BIO vs CX Comparison

BIO vs CX Comparison

Compare BIO & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CX
  • Stock Information
  • Founded
  • BIO 1952
  • CX 1906
  • Country
  • BIO United States
  • CX Mexico
  • Employees
  • BIO N/A
  • CX N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CX Building Materials
  • Sector
  • BIO Industrials
  • CX Industrials
  • Exchange
  • BIO Nasdaq
  • CX Nasdaq
  • Market Cap
  • BIO 8.7B
  • CX 9.5B
  • IPO Year
  • BIO N/A
  • CX 1999
  • Fundamental
  • Price
  • BIO $318.98
  • CX $5.77
  • Analyst Decision
  • BIO Buy
  • CX Buy
  • Analyst Count
  • BIO 4
  • CX 6
  • Target Price
  • BIO $369.00
  • CX $8.87
  • AVG Volume (30 Days)
  • BIO 215.9K
  • CX 13.0M
  • Earning Date
  • BIO 10-24-2024
  • CX 10-24-2024
  • Dividend Yield
  • BIO N/A
  • CX 0.72%
  • EPS Growth
  • BIO N/A
  • CX N/A
  • EPS
  • BIO N/A
  • CX 0.01
  • Revenue
  • BIO $2,562,604,000.00
  • CX $17,516,921,000.00
  • Revenue This Year
  • BIO N/A
  • CX $6.60
  • Revenue Next Year
  • BIO $4.49
  • CX $3.37
  • P/E Ratio
  • BIO N/A
  • CX $48.04
  • Revenue Growth
  • BIO N/A
  • CX 7.77
  • 52 Week Low
  • BIO $261.59
  • CX $5.50
  • 52 Week High
  • BIO $384.37
  • CX $9.27
  • Technical
  • Relative Strength Index (RSI)
  • BIO 46.65
  • CX 39.68
  • Support Level
  • BIO $326.40
  • CX $5.63
  • Resistance Level
  • BIO $337.50
  • CX $5.95
  • Average True Range (ATR)
  • BIO 8.71
  • CX 0.22
  • MACD
  • BIO -1.26
  • CX -0.05
  • Stochastic Oscillator
  • BIO 33.23
  • CX 21.72

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services.

Share on Social Networks: